News & Media
Press Releases
Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage
Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and metabolic diseases, today announced the appointment of Pierre Legault, MBA, CPA as director and chairman of its board of directors…
Alizé Pharma 3 Announces Rebranding to Amolyt Pharma, Reflecting a Strategic Focus on Building and Advancing a Portfolio of Therapeutic Peptides for Rare Endocrine and Metabolic Diseases
Alizé Pharma 3 Announces Rebranding to Amolyt Pharma, Reflecting a Strategic Focus on Building and Advancing a Portfolio of Therapeutic Peptides for Rare Endocrine and …
Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate
Amolyt Pharma 3 announces that it has completed a €67 million Series A financing round …
Presentations
- All PRESENTATIONS
- AZP-3404
- AZP-3601
- All PRESENTATIONS
- AZP-3404
- AZP-3601
Upcoming events
90th Annual Meeting of the American Thyroid Association®
Date: September 29 – October 3, 2021 (Virtual)
Hypopara Patient Association Meeting
Date: October 2021
ASBMR 2021 Annual Meeting
Date: October 1-4, 2021 (Toronto)
37eme Congrès de la Société Française d’Endocrinologie (SFE)
Date: October 13-16, 2021 (Le Havre)
AMCP Nexus 2021
Date: October 19-22, 2021 (Denver, CO)
American Society of Nephrology (ASN) Kidney Week 2021
Date: November 2-7, 2021 (San Diego, CA)
Acromegaly Awareness Day
Date: November 1, 2021
Social Updates
TWITTER